NCT01240824
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +13 more
- Locations
-
- University of Virginia Urology Department Charlottesville, Virginia, United States
Clinical trial condition
Carcinoma, Transitional Cell
Explore clinical trials studying Carcinoma, Transitional Cell. Study availability and eligibility vary by location and protocol.
417 public trials
125 recruiting studies
Carcinoma, Transitional Cell trial results
NCT01395225
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
- Locations
-
- Vancouver General Hospital Vancouver, British Columbia, Canada
NCT00714025
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, NOG-Related-Symphalangism Spectrum Disorder, +4 more
- Locations
-
- Cliniques Universitaires St Luc-UCL Brussels, Belgium
NCT01426126
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +16 more
- Locations
-
- Asan Medical Center Seoul, South Korea
NCT00101608
- Conditions
- Bladder Cancer, Bladder Neoplasms, Carcinoma, +21 more
- Locations
-
- Local Institution Beverly Hills, California, United States
- Local Institution La Jolla, California, United States
- Local Institution Los Angeles, California, United States
- Local Institution Santa Monica, California, United States
NCT00315237
- Conditions
- Bladder Cancer, Bladder Neoplasms, Carcinoma, +15 more
- Locations
-
- Local Institution Calgary, Alberta, Canada
- Local Institution Edmonton, Alberta, Canada
- Local Institution Vancouver, British Columbia, Canada
- Local Institution Victoria, British Columbia, Canada
NCT00077688
- Conditions
- Bladder Neoplasms, Carcinoma, Carcinoma, Transitional Cell, +17 more
- Locations
-
- University of Maryland Medical Center/Greenbaum Cancer Center Baltimore, Maryland, United States
- Cleveland Clinic Foundation Cleveland, Ohio, United States
- University of Washington/Seattle Cancer Care Alliance Seattle, Washington, United States
NCT00216801
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +25 more
- Locations
-
- St. Josephs Health Care London, Ontario, Canada
Completed
A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder
NCT00001381
- Conditions
- Bladder Neoplasms, Carcinoma, Carcinoma, Transitional Cell, +13 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
NCT00393809
- Conditions
- Bladder Neoplasms, Carcinoma, Carcinoma, Transitional Cell, +13 more
- Locations
-
- E. Wolfson Medical Center Holon, Israel
- Meir Medical Center Kfar Saba, Israel